First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

Didier Meulendijks, Wolfgang Jacob, Maria Martinez-Garcia, Alvaro Taus, Martijn P Lolkema, Emile E Voest, Marlies H G Langenberg, Tania Fleitas Kanonnikoff, Andres Cervantes, Maja J De Jonge, Stefan Sleijfer, Morten Mau-Sørensen, Marlene Thomas, Maurizio Ceppi, Georgina Meneses-Lorente, Ian James, Celine Adessi, Francesca Michielin, Keelara Abiraj, Birgit BossenmaierJan H M Schellens, Martin Weisser, Ulrik Niels Lassen

38 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab